| Literature DB >> 20556439 |
Mark Arts1, Ronald Brand, Bas van der Kallen, Geert Lycklama à Nijeholt, Wilco Peul.
Abstract
The concept of minimally invasive lumbar disc surgery comprises reduced muscle injury. The aim of this study was to evaluate creatine phosphokinase (CPK) in serum and the cross-sectional area (CSA) of the multifidus muscle on magnetic resonance imaging as indicators of muscle injury. We present the results of a double-blind randomized trial on patients with lumbar disc herniation, in which tubular discectomy and conventional microdiscectomy were compared. In 216 patients, CPK was measured before surgery and at day 1 after surgery. In 140 patients, the CSA of the multifidus muscle was measured at the affected disc level before surgery and at 1 year after surgery. The ratios (i.e. post surgery/pre surgery) of CPK and CSA were used as outcome measures. The multifidus atrophy was classified into three grades ranging from 0 (normal) to 3 (severe atrophy), and the difference between post and pre surgery was used as an outcome. Patients' low-back pain scores on the visual analogue scale (VAS) were documented before surgery and at various moments during follow-up. Tubular discectomy compared with conventional microdiscectomy resulted in a nonsignificant difference in CPK ratio, although the CSA ratio was significantly lower in tubular discectomy. At 1 year, there was no difference in atrophy grade between both groups nor in the percentage of patients showing an increased atrophy grade (14% tubular vs. 18% conventional). The postoperative low-back pain scores on the VAS improved in both groups, although the 1-year between-group mean difference of improvement was 3.5 mm (95% CI; 1.4-5.7 mm) in favour of conventional microdiscectomy. In conclusion, tubular discectomy compared with conventional microdiscectomy did not result in reduced muscle injury. Postoperative evaluation of CPK and the multifidus muscle showed similar results in both groups, although patients who underwent tubular discectomy reported more low-back pain during the first year after surgery.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20556439 PMCID: PMC3036021 DOI: 10.1007/s00586-010-1482-y
Source DB: PubMed Journal: Eur Spine J ISSN: 0940-6719 Impact factor: 3.134
Summary of baseline characteristics in both treatment groups
| Characteristics | Tubular discectomy ( | Conventional microdiscectomy ( |
|
|---|---|---|---|
| Age (years) | 41.0 ± 10.0 | 40.8 ± 11.7 | 0.91 |
| Female sex—no (%) | 53(48) | 48(45) | 0.67 |
| Duration of sciatica (weeks) | 32.6 ± 57.2 | 26.2 ± 22.4 | 0.28 |
| Body mass index (kg/l²) | 25.8 ± 4.3 | 25.3 ± 4.1 | 0.36 |
| Current smoker—no (%) | 37(34) | 44(42) | 0.49 |
| Disc herniation level—no (%) | |||
| L3–L4 | 2(2) | 3(3) | 0.82 |
| L4–L5 | 44(40) | 37(35) | |
| L5–S1 | 64(58) | 66(62) | |
| Roland-Morris disability questionnaire score | 16.2 ± 4.4 | 16.3 ± 4.4 | 0.88 |
| VAS score leg pain (mm) | 61.9 ± 20.6 | 62.3 ± 24.3 | 0.90 |
| VAS score low-back pain (mm) | 39.7 ± 25.5 | 39.9 ± 27.8 | 0.96 |
Plus-minus values are means ± standard deviations
VAS visual analogue scale
Surgical characteristics and postoperative course
| Characteristics | Tubular discectomy ( | Conventional microdiscectomy ( |
|
|---|---|---|---|
| Operation time (min) | 47.3 ± 22.7 | 35.3 ± 16.2 | <0.001 |
| Blood loss < 50 ml—no (%) | 103(94) | 92(87) | 0.28 |
| Day of mobilization—no (%) | |||
| Same day of surgery | 51(46) | 53(50) | 0.86 |
| Day 1 | 58(53) | 52(49) | |
| Day 2 | 1(1) | 1(1) | |
| Hospital stay (days) | 3.3 ± 1.1 | 3.3 ± 1.1 | 0.61 |
Plus-minus values are means ± standard deviations
Serum level creatine phosphokinase before surgery (CPK1) and 1 day after surgery (CPK2)
| Creatine phosphokinase | Tubular discectomy ( | Conventional microdiscectomy ( |
|
|---|---|---|---|
| CPK1 (IU/l) | 105.8 ± 65.5 | 107.1 ± 59.8 | 0.88 |
| CPK2 (IU/l) | 255.7 ± 209.8 | 268.1 ± 242.4 | 0.69 |
| CPK ratio | 2.75 ± 2.26 | 2.65 ± 2.23 | 0.74 |
| Log (CPK ratio) | 0.33 ± 0.31 | 0.31 ± 0.32 | 0.65 |
The CPK ratio (CPK2/CPK1) represents the difference within one patient. Because CPK1 and CPK2 were not normally distributed and slightly skewed, the log transform of the CPK ratio was also performed. Plus-minus values are means ± standard deviations
CPK creatine phosphokinase
CSA (in mm²) of the multifidus muscle at the side of the disc herniation, is measured before surgery (CSA 1), and 1 year after surgery (CSA 2)
| Unilateral multifidus muscle | Tubular discectomy ( | Conventional microdiscectomy ( |
|
|---|---|---|---|
| CSA 1 (mm²) | 832 ± 206 | 817 ± 209 | 0.67 |
| CSA 2 (mm²) | 821 ± 238 | 846 ± 229 | 0.54 |
| CSA ratio | 0.99 ± 0.14 | 1.05 ± 0.19 | 0.04 |
| Mean multifidus atrophy score (0–3) | 1.22 ± 0.83 | 1.31 ± 0.78 | 0.64 |
| 0—normal | 14 | 11 | |
| 1—mild | 32 | 27 | |
| 2—moderate | 22 | 28 | |
| 3—severe | 4 | 2 | |
| Change in atrophy score | 0.65* | ||
| 0—constant | 62 (86%) | 56 (82%) | |
| 1—deteriorated (+1 point) | 10 (14%) | 12 (18%) | OR 1.3 (95% CI, 0.5 to 3.3)** |
The CSA ratio (CSA2/CSA1) represents the difference of cross-sectional muscle area within one patient. The mean multifidus atrophy score was calculated at 1 year after surgery, followed by the distribution in grade 0 to grade 3. Plus-minus values are means ± standard deviations
CSA cross sectional area; OR odss ratio; CI confidence interval
* Fisher exact test (2-sided)
** Odss ratio of atrophy deterioration in the conventional group versus tubular group
Fig. 1During the first year after surgery, the VAS score for low-back pain improved in both groups. The 1-year between-group mean difference in improvement was 3.5 mm (95% CI, 0.1–6.9 mm) in favour of conventional microdiscectomy